TTOO — T2 Biosystems Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.02m
- $9.86m
- $7.19m
Brief: T2 Biosystems Enters Amendment No. 12 To Term Loan Agreement
Brief: T2 Biosystems Announces Exclusive US Agreement With Cardinal Health To Sell Its FDA-Cleared Direct-From-Blood Diagnostics For Rapid Detection Of Sepsis-Causing Pathogens
T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary
Brief: T2 Biosystems Announces Commercial Expansion Through Malaysia And Indonesia Distributor
T2 Biosystems Inc expected to post a loss of 97 cents a share - Earnings Preview
Brief: T2 Biosystems Inc Files For Mixed Shelf Of Up To $150 Million - SEC Filing
Brief: T2 Biosystems Execution Of Territory Exclusive Distribution Agreement In Hong Kong And Macau
Brief: T2 Biosystems Regains Compliance With Nasdaq Continued Listing Requirements
Brief: T2 Biosystems Announces Closing Of $8 Mln Private Placement Priced At-The-Market Under Nasdaq Rules
Brief: T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Brief: T2 Biosystems Announces Letter Of Intent To Enter Strategic Partnership For Lyme Disease
T2 Biosystems Inc reports results for the quarter ended in March - Earnings Summary
Brief: T2 Biosystems Announces Conversion Of An Additional $15 Mln Of CRG Term Loan Into Equity
Brief: T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
Brief: T2 Biosystems- Files For Offering Of Up To 3.32 Million Shares Of Common Stock
T2 Biosystems Inc expected to post a loss of $1.86 a share - Earnings Preview
Brief: T2 Biosystems Shareholders Vote For CRG Debt Conversion Into Equity
Brief: T2 Biosystems Announces Extension Of Multi-Year Capital Equipment Supplier Agreement With Vizient
Brief: T2 Biosystems Announces Commercial Expansion Through Distributors In Europe And Asia